Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00923013
Title Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

hairy cell leukemia

Therapies

Cladribine

Rituximab

Cladribine + Rituximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.